Retina4Future - COST Action CA24105

Short Bio: As the Chief Operating Officer at Miramoon Pharma, I bring over two decades of experience spanning developmental neuroscience, regenerative therapies, and the pharmaceutical industry. Since transitioning to the corporate sector in 2020, I have successfully led R&D strategies, regulatory activities with the EMA, and strategic partnerships, driving innovation from the laboratory to patient-oriented solutions. I hold a PhD in Neuroscience from Miguel Hernández University and have conducted research at world-renowned institutions, including The Scripps Research Institute and UCSF. My scientific contributions include numerous publications in high-impact journals like Science and Neuron. Additionally, I represent Spain on the Management Committee of the pan-European COST Action Retina4Future.